foxo4-dri peptide mechanism of action Molecular modelling of the FOXO4-TP53

Third-party HPLC validated to 99%+ purity

These two studies cloned and identified SREBP1c (ADD1) as a member of the bHLH leucine zipper family that regulates both hepatic lipid metabolism and adipogenesis

Quick Comparison Feature CagriSema Retatrutide Development owner Novo Nordisk Eli Lilly Core strategy Combination therapy Single-molecule multi-agonist Pathways Amylin + GLP-1 GIP + GLP-1 + glucagon Main components Cagrilintide + semaglutide Retatrutide (LY3437943) 2026 status Phase 3 / regulatory-watch candidate Phase 3 TRIUMPH program Best-fit research question Can amylin extend GLP-1 results

Maintenance phase: After loading, protocols typically reduce to 2-2.5mg once weekly or 2mg twice monthly